Highlights
|
Aim
Intensive glycemic control reduces the risk of renal, retinal, and neurological complications in type 1 diabetes (T1D), but it is unknown whether it reduces the risk of lower extremity complications.
We examined whether intensive versus conventional glycemic control among Diabetes Control and Complications Trial (DCCT) participants with T1D reduced the long-term risk of diabetic foot ulcers (DFU) and lower extremity amputations (LEA) in the Epidemiology of Diabetes Interventions and Complications Study (EDIC).
Methodology
DCCT participants (n = 1,441) completed an average of 6.5 years of intensive versus conventional diabetes treatment, after which 1,408 were enrolled in EDIC and followed annually for 23 years for occurrences of DFU. and LEA through physical examination.
Multivariable Cox proportional hazard regression models estimated the associations of DCCT treatment assignment and time-updated exposures with DFU or LEA.
Results
Intensive versus conventional glycemic control was associated with a significant risk reduction for all DFUs (hazard ratio 0.77 [95% CI: 0.60, 0.97]) and a risk reduction of similar magnitude but not significant for the first registered UPDs (0.78 [0.59, 1.03]) and first LEAs (0.70 [0.36, 1.36]).
In adjusted Cox models, clinical neuropathy, lower sural nerve conduction velocity, and cardiovascular autonomic neuropathy were associated with increased risk of DFU; estimated glomerular filtration rate <60 ml/min/1.73 m2, albuminuria and macular edema with increased risk of LEA; and any retinopathy and higher DCCT/EDIC time-weighted mean HbA1c with higher risk of both outcomes (P < 0.05).
Conclusions
Early intensive glycemic control decreases the risk of long-term DFU, the most important antecedent in the causal pathway of LEA.